NIMBB Forums: Gene Therapy for Rare Diseases: Insights from the AAV-NF2 Gene Therapy Program

NIMBB Forums: Gene Therapy for Rare Diseases: Insights from the AAV-NF2 Gene Therapy Program

Gene therapy is transforming how we approach rare diseases.

Join us for a webinar on “Gene Therapy for Rare Diseases: Insights from the AAV-NF2 Gene Therapy Program”, where experts will discuss vector design, translational research, and ongoing efforts to develop gene therapies for Neurofibromatosis Type 2 (NF2).

🗓 April 13, 2026
⏰ 8:00 AM (Philippine Time)

🔗 Register: tinyurl.com/nimbb-webinars-nch1
📱 Or scan the QR code on the poster.

MS Thesis Defense: Marian Gayle Guevara

MS Thesis Defense: Marian Gayle Guevara

You are all invited to the MS Thesis Defense of Marian Gayle Guevara of SML.

She will be presenting her work entitled: “Development of a Point-of-Care (POC) Molecular-based CRISPR-Diagnostic platform against SARS-CoV-2 and SARS-CoV-2 Variants.”

Date: May 28, 2025 (Wednesday), 9:00 AM
Venue: NIMBB Lecture Room 107
Date and Time: Dec. 17, 2024, 1 PM
Place: NIMBB Room 107

MBB 294 Culminating Activity: The Genesis Project – Engineering the Future of Humanity

MBB 294 Culminating Activity: The Genesis Project – Engineering the Future of Humanity

Join us in the NIMBB Conference Room this Friday, May 16, 2025, at 2:00 p.m. for the culminating event of MBB 294: Ethics in Research. In this deliberative policy simulation entitled “The Genesis Project: Engineering the Future of Humanity,” we will tackle the challenges of science governance from the perspective of scientists, ethicists, religious leaders, human rights advocates, political leaders, and international bodies in a future where gene editing could reshape humanity.

MBB 196 Undergraduate Seminar: Breaking the Resistance – Dual FGFR and AKT Inhibition in NSCLC

MBB 196 Undergraduate Seminar: Breaking the Resistance – Dual FGFR and AKT Inhibition in NSCLC

This seminar will discuss the rationale and preclinical evidence supporting the combined inhibition of EGFR and Akt pathways as a targeted strategy to restore drug sensitivity in FGFR1-overexpressing NSCLC models. The dual inhibition approach has demonstrated superior efficacy compared to monotherapies and offers a promising direction for the development of next-generation combination treatments in precision oncology.

Join us on Friday, May 16 for the MBB 196 Undergraduate Seminar, to be held at the National Institute of Molecular Biology and Biotechnology (NIMBB), Room 105, at 1:00 PM. All are welcome to attend.

MBB 196 Undergraduate Seminar: A Prostrate-ing Problem and Synergistic Solutions

MBB 196 Undergraduate Seminar: A Prostrate-ing Problem and Synergistic Solutions

Join us this Friday, April 25, 2025, at 1:00 pm in NIMBB Room 105 for a discussion on novel therapeutic approaches for prostate cancer treatment with a focus on the synergy of endosomal recycling inhibitors (ERI) and enzalutamide. Gain valuable insights on how this combination may be translated into clinical practice.
See you then!

MBB 196 Undergraduate Seminar: Microbial Metalheads: Quorum Sensing and Bioluminescence – mechanism, regulation, variations

MBB 196 Undergraduate Seminar: Microbial Metalheads: Quorum Sensing and Bioluminescence – mechanism, regulation, variations

Join the MBB 196 Undergraduate Seminar to be held this Friday (March 28, 2025) to learn more about how the QS circuit of V. campbellii BB120 differs from canonical QS systems and why V. campbellii DS40M4’s QS circuit suggests the possibility of new regulators. The seminar will be held from 1 PM to 2 PM in Room 105, NIMBB, UP-Diliman. See you there!